Our findings indicated that several risk genes, such as LGALS1 and PLA2G5, were highly expressed in M2 macrophages, underscoring their potential role in promoting the immunosuppressive microenvironment that supports GBM progression. The gene discussed is LGALS1; the disease is glioblastoma.